• No results found

[PDF] Top 20 Current concepts in multiple sclerosis therapy

Has 10000 "Current concepts in multiple sclerosis therapy" found on our website. Below are the top 20 most common "Current concepts in multiple sclerosis therapy".

Current concepts in multiple sclerosis therapy

Current concepts in multiple sclerosis therapy

... progressive multiple sclerosis (2005 revised McDonald cri- teria), were older (median age 46 years), had an EDSS score of ...progressive multiple sclerosis patients were ... See full document

17

Therapy optimization in multiple sclerosis: a prospective observational study of therapy compliance and outcomes

Therapy optimization in multiple sclerosis: a prospective observational study of therapy compliance and outcomes

... Longitudinal Multiple Sclerosis Study in the US which looked at natural history of MS and The Global Adherence Project (GAP) conducted in twenty-two other countries, TOP MS had comparable proportions of ... See full document

9

Optimal management of multiple sclerosis during pregnancy: current perspectives

Optimal management of multiple sclerosis during pregnancy: current perspectives

... IFN- β during the conception period and the first weeks of pregnancy seems to be relatively safe. It has become increas- ingly common to continue IFN- β until pregnancy has been confirmed. Given that it is not known when ... See full document

10

Pathophysiological Concepts in Multiple Sclerosis and the Therapeutic Effects of Hydrogen Sulfide

Pathophysiological Concepts in Multiple Sclerosis and the Therapeutic Effects of Hydrogen Sulfide

... Unfortunately, the current immune-based therapies have little, if any, effect on MS progression. This situation calls for introduction and development of new molecules or thera- peutic systems, which could tackle ... See full document

16

MR Imaging in Multiple Sclerosis: Review and Recommendations for Current Practice

MR Imaging in Multiple Sclerosis: Review and Recommendations for Current Practice

... to therapy in individual ...to therapy, a rational approach is baseline assessment with follow-up at 3 or 6 months and again at 12 ...in therapy or the need for more frequent ...that therapy ... See full document

7

Respiratory therapy for speech in multiple sclerosis

Respiratory therapy for speech in multiple sclerosis

... of multiple neuro-motor systems in MS and consequentially the difficulty in identifying the probable source of a particular speech ...speech therapy because of the inevitability of further deterioration and ... See full document

307

NORdic trial of oral Methylprednisolone as add-on therapy to Interferon beta-1a for treatment of relapsing-remitting Multiple Sclerosis (NORMIMS study): a randomised, placebo-controlled trial

NORdic trial of oral Methylprednisolone as add-on therapy to Interferon beta-1a for treatment of relapsing-remitting Multiple Sclerosis (NORMIMS study): a randomised, placebo-controlled trial

... progressive multiple sclerosis, had a history of peptic ulcer or current symptoms of dyspepsia, diabetes mellitus, alcohol or drug abuse, major depression, cardiac or renal insufficiency, or other ... See full document

14

Alemtuzumab: A Place in Therapy for Treatment of Multiple Sclerosis

Alemtuzumab: A Place in Therapy for Treatment of Multiple Sclerosis

... While current evidence is not suffi- ciently robust to confirm an increased risk of developing MS in patients with prior EBV infection, research of the association remains plausible ... See full document

13

Physical therapy for individuals with amyotrophic lateral sclerosis: current insights

Physical therapy for individuals with amyotrophic lateral sclerosis: current insights

... The effects of exercise in PALS are not well understood, and the role of resistance and aerobic exercise, and fitness in gen- eral, for those with ALS does continue to be controversial. The role of exercise in ALS has ... See full document

10

Caught in a no-win situation: discussions about CCSVI between persons with multiple sclerosis and their neurologists – a qualitative study

Caught in a no-win situation: discussions about CCSVI between persons with multiple sclerosis and their neurologists – a qualitative study

... of therapy, of success rates (includ- ing long term versus short term), and of the safety of using angioplasty – a treatment developed for arteries – on jugular ...access therapy, clinicians often claimed ... See full document

17

Multiple Sclerosis: A Review of Existing Therapy and Future Prospects

Multiple Sclerosis: A Review of Existing Therapy and Future Prospects

... exciting concepts emerging in the treatment of multiple sclerosis include recombinant myelin, basic protein as a more specific antigen to induce oral tolerance instead of oral myelin, protein growth ... See full document

8

Patient preferences for treatment of multiple sclerosis with disease-modifying therapies: a discrete choice experiment

Patient preferences for treatment of multiple sclerosis with disease-modifying therapies: a discrete choice experiment

... Results: A total of 125 patients were included in the final analysis (62.9% female, mean age 44.5 years, 71.5% with relapsing-remitting MS diagnosis). The most important factor for patients was the possibility of ... See full document

12

Effects of Self-Care Training on MS Patients’ Hope Rate by Group Discussion

Effects of Self-Care Training on MS Patients’ Hope Rate by Group Discussion

... Group Therapy on Life Expectancy and Hope Rate of Patients with Multiple Sclerosis” shows that the average score of well-being and hope rate in Azemayesh group turned up to be significantly higher ... See full document

5

Multiple Sclerosis, Physical Therapy, and Quality of Life Insights

Multiple Sclerosis, Physical Therapy, and Quality of Life Insights

... A sense of control and active physical and mental participation is notably unique to PT in comparison to drug therapy. According to patients, benefits of medicine are less apparent, which often leads to ... See full document

8

Identifying responders and nonresponders to interferon therapy in multiple sclerosis

Identifying responders and nonresponders to interferon therapy in multiple sclerosis

... of therapy: the condition of the patient before treatment and adaptive changes during therapy, eg, certain human leukocyte antigen alleles, or single nucleotide polymorphisms in the interferon alpha/beta ... See full document

10

Features of Coping with Disease in Iranian Multiple Sclerosis
Patients: a Qualitative Study

Features of Coping with Disease in Iranian Multiple Sclerosis Patients: a Qualitative Study

... the current position along with accepting the realities of the disease, the chronic nature, treatment, complications of the disease are symptoms of coping with the ... See full document

6

Parkinsonism associated with multiple sclerosis: A report of eight new cases and a review on the literature.

Parkinsonism associated with multiple sclerosis: A report of eight new cases and a review on the literature.

... Rapidly progressive course of very late onset multiple sclerosis presenting with Parkinsonism: case report. Multiple sclerosis[r] ... See full document

6

Multiple sclerosis: patients’ information sources and needs on disease symptoms and management

Multiple sclerosis: patients’ information sources and needs on disease symptoms and management

... This study reports on the current, actual, and desired informa- tion needs of MS patients in the early stages of their disease. Participants have identified that they receive most information from the MS Society ... See full document

5

Management of multiple sclerosis in adolescents – current treatment options and related adherence issues

Management of multiple sclerosis in adolescents – current treatment options and related adherence issues

... Adolescents’ dependence on long-term treatment, need for self-management, physical limitations, and unpredictabil- ity of the disease magnifies the differences between these youth and their peers, thus increasing the ... See full document

13

Assessment of bone marrow derived Cellular Therapy in progressive Multiple Sclerosis (ACTiMuS): study protocol for a randomised controlled trial

Assessment of bone marrow derived Cellular Therapy in progressive Multiple Sclerosis (ACTiMuS): study protocol for a randomised controlled trial

... in multiple central nervous system (CNS) path- ways collated as a composite score known as the glo- bal evoked potential (GEP) [2, 3] improved in all patients studied ( n = 6) ... See full document

8

Show all 10000 documents...